The nursing assistant, who has not been identified, received
AstraZeneca's shot on March 12 and later suffered from double vision
and paralysis and was diagnosed with acute encephalomyelitis, the
state-run Korea Workers' Compensation & Welfare Service said on
Friday.
The service said in a statement the woman did not have underlying
conditions and there seemed to be a "a reasonable causal link
between the side effects and the vaccination".
AstraZeneca, asked about the case, did not refer to it directly but
said patient safety was of the utmost importance for it and
regulators around the world.
"International regulators, including the World Health Organization,
continue to reaffirm that the vaccine offers a high-level of
protection against all severities of COVID-19 and variants of
concern, and is a key part of global efforts to overcome the virus,"
AstraZeneca said in a statement.
The Korea Disease Control and Prevention Agency (KDCA) had
determined that with the available evidence, it could not verify a
connection between the woman's case and the vaccine but it was open
to re-evaluation when more evidence was available, said agency
official Choi Seung-ho.
South Korea, like many other countries, has indemnified major
vaccine makers against claims and set up funds to cover any costs.
It offers up to 10 million won ($8,747) to anyone who suffers
serious side effects from the coronavirus vaccines but this is the
first case in which the side effects are considered an industrial
accident.
Healthcare workers were among the first to be eligible for the
vaccines in South Korea and were encouraged by employers to be
vaccinated but they were not forced to.
The compensation service concluded that the woman was eligible for
government compensation and benefits under the Industrial Accident
Compensation Insurance Act because her medical situation was related
to her work.
She will be compensated for missed work hours and benefits will
cover her medical expenses and disabilities, the service spokesman
told Reuters. There were six more cases pending a decision, the
spokesman said.
The KDCA said a total of 1,562 cases, including 14 deaths, had been
reviewed for compensation regarding damages from COVID-19
vaccination, of which 983 had been compensated. There has been no
compensation for a case involving a death.
[to top of second column] |
LIABILITY AND CLAIMS
AstraZeneca has been granted protection from
product liability claims related to its COVID-19
vaccine by most of the countries with which it
has struck supply agreements.
After reports of a rare blood clots associated
with the vaccine this year, several countries
announced restrictions on its use in younger
people.
In Asia, countries including Singapore,
Australia, Thailand and Malaysia have financial
assistance programmes or set up compensation
funds for those who suffer serious side effects
from vaccines.
In Thailand, the government has paid out 13
million baht ($389,454) to 400 cases of COVID-19
vaccine side-effects, its health agency said. In
cases of death, it pays 400,000 baht, and side
effects that impact daily life, 240,000 baht.
Payments are not proof, however, that the
vaccines have side effects, it said, because
that is under the purview of an expert panel.
This year, the World Health Organization agreed
https://www.reuters.com/
article/uk-health-coronavirus-who-vaccines-compe-idUSKBN2AN0GV
a no-fault compensation plan for claims of
serious side effects in people in 92 poorer
countries due to get COVID-19 vaccines via the
COVAX sharing scheme.
India, which has the second-highest number of
cases globally, is a holdout
https://statics.teams.cdn.office.net/
evergreen-assets/safelinks/1/atp-safelinks.html.
The government is in talks over legal protection
sought by companies like Pfizer and Moderna, and
no shots have been shipped by these companies.
The U.S. government has compensation fund for
people who are victims of side effects of a
vaccine, but lawyers say few claims have been
compensated
https://statics.teams.cdn.office.net/
vergreen-assets/safelinks/1/atp-safelinks.html
historically.
($1 = 33.3800 baht)
(Reporting by Sangmi Cha; Additional reporting
by Panarat Thepgumpanat and Chayut Setboonsarng;
Writing by Josh Smith; Editing by Sayantani
Ghosh, Robert Birsel)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |